Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_assertion type Assertion NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_head.
- NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_assertion description "[Epigenetic silencing of RASSF1A is a frequent event in non-small lung cancer and will provide novel opportunities to develop diagnosis and therapy of NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_provenance.
- NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_assertion evidence source_evidence_literature NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_provenance.
- NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_assertion SIO_000772 12794755 NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_provenance.
- NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_assertion wasDerivedFrom befree-20140225 NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_provenance.
- NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_assertion wasGeneratedBy ECO_0000203 NP162923.RAAKDwy1RRd0yCfXlLS1y_VLnIuU3KqJoagTwyNBxguEA130_provenance.